Centrum kardiovaskulární medicíny s.r.o

The research at Centrum kardiovaskulární medicíny s.r.o in Prague focuses on cardiovascular diseases, with studies centered on atherosclerotic cardiovascular disease and related risk reduction. The trials are designed to evaluate whether new approaches can lower major heart and blood vessel complications and improve prevention for people at elevated risk.

• Atherosclerotic cardiovascular disease
• Elevated lipoprotein(a)
• Major adverse cardiovascular events

These trials are mainly aimed at testing whether emerging therapies can reduce serious cardiovascular outcomes such as heart attack, stroke, and urgent revascularization, while also improving overall risk management.

This site also contributes to research in nutritional and metabolic diseases, especially obesity and overweight. The studies explore whether new treatments can help people living with excess weight and associated health risks, including complications affecting the heart and kidneys.

• Obesity
• Overweight
• Kidney outcomes

The main purpose is to assess treatment effectiveness in lowering cardiovascular risk and protecting kidney function, supporting better long-term outcomes for patients with metabolic disease.